Completed
Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis
NCT02718495
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
- Locations
-
- Stanford University Medical Center Stanford, California, United States
- Central Florida Pulmonary Group Altamonte Springs, Florida, United States
- University of Florida College of Medicine Gainesville, Florida, United States
- St. Luke's Cystic Fibrosis Center of Idaho Boise, Idaho, United States